Dassault Systemes to Buy Accelrys for $750M | GenomeWeb

NEW YORK (GenomeWeb News) – Dassault Systèmes and Accelrys today announced that they have signed a definitive merger agreement under which Dassault Systèmes will acquire the San Diego-based software company in an all-cash $750 million transaction.

Dassault Systèmes said Thursday that it will make a tender offer to acquire all the outstanding shares of Accelrys common stock for $12.50 per share. Accelrys shares closed at $9.72 in Wednesday trade on the Nasdaq.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.